Keywords: actelion, tracleer, active, pah, analysis, open-label, study

Actelion's Tracleer active in PAH

Article | 08 September 2003

Print This

Analysis of an open-label study with Swiss firm Actelion's Tracleer (bosentan) in the treatment of pulmonary arterial hypertension related to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in